Green Thumb at 13.5x Earnings Is Underpriced If May Q1 Holds Up

Green Thumb looks cheap relative to current earnings power

If the latest quarter holds up, Green Thumb looks cheap enough to matter now. At a 13.49 price-to-earnings ratio, the stock is still being valued like a distressed cannabis name even after $300.2 million of Q1 revenue and $76.0 million of cash flow from operations. That is the core setup: if profits and cash generation are becoming durable, sentiment has not fully caught up.

The valuation gap is visible in the tape

This is not a future-tense story. Green Thumb already has current earnings power, and the market is assigning it a modest multiple. Shares recently traded at $6.46 after trading in a narrow band in spring 2026, well below the 52-week high of $10.43. That gap usually means one of two things: either the business is heading for a problem, or sentiment has not yet adjusted to the numbers.

Buybacks strengthen the case that the discount is too wide

The stronger clue is capital allocation. Green Thumb spent about $33.3 million on repurchases in the quarter. When a company turns current earnings into buybacks, it suggests management sees value. Bears will argue cannabis still carries stigma and operating risk. It does. But that stigma may also be keeping the shares pinned near the low end of their range.

The next earnings report is the catalyst that can close that gap. If management shows this quarter was a base rather than a one-off burst, the stock becomes less of a speculative "maybe" and more of a valuation-catch-up trade.

Green Thumb's recent pressure points help explain the discount

The market is not ignoring the operating data. It is weighing that data against lingering sector fear.

The headline concerns came from retail

Recent concerns centered on performance in its retail segment. In a less biased setting, investors would have weighed those setbacks against the company's stronger profit base and cash generation while waiting for management commentary on causes and fixturing. Instead, the reaction looked more like a stress test. The issue is most visible in retail, where softness feels immediate, so traders were quick to treat localized pressure as evidence of a broader problem.

Why cannabis names often get judged more harshly

• Confirmation bias: Investors already primed to view cannabis operators as too risky can lean too quickly on one weak quarter as proof of a deeper problem.
• Overconfidence in the bear case: A comp decline can come from temporary pricing pressure, inventory timing, or state mix changes; margin pressure can be channel-specific rather than model-wide.
• Loss aversion: In a stigmatized sector, investors have often been punished for being early. That can keep a stock cheap even when the latest quarter is weaker than the market reaction implies.

The decision point is straightforward: if these are one-quarter noise items, the discount should narrow. If the next update shows retail still soft and margins still slipping, the market's caution was justified.

May 2026 results are the real decision point

The next report will test whether the quarter was sustainable

The market will get its answer on May 6, 2026, when Green Thumb reports after the close and holds its conference call at 5:00 p.m. ET. That is why now matters: this is the first hard check on whether the business can move from a good start to a sustainable run rate. If management offers only reassuring language without fresh proof, cautious investors will stay cautious. If the quarter validates the earlier momentum, the stock's problem shifts from fundamentals to perception.

What would support a re-rating

For the market to price the shares more aggressively, the next update needs to answer three questions clearly:

• Did momentum continue?
• Did retail pressure ease or stabilize?
• Is profitability discipline holding?

There is also a capital-allocation trigger. Green Thumb ended the prior quarter with $344.5 million in cash and repurchased shares during the quarter. If buybacks continue or management points to added flexibility for growth and shareholder returns, that would matter. A cheap-looking stock with cash and retiring shares is easier to rerate because execution can support both earnings per share and investor confidence.

What would invalidate the thesis

Skeptics can argue that one soft quarter is all it takes to break the narrative, and that is a real risk. If the next report shows renewed margin pressure, weaker retail performance, or more cautious guidance, the market will treat the earlier strength as noise. In that case, the discount likely stays in place.

A buy-on-proof stance

This is not a blind leap. The more disciplined stance is to respect the $6.46 level, but become more constructive only if the next report delivers proof. If management confirms momentum, stabilizes the retail narrative, and keeps the balance sheet as strong as the current cash position suggests, the current mid-$6 area could look less like fair value and more like a window before consensus catches up.